External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology Squamous Cell Cancer

Squamous Cell Cancer

What's new

Sign up or login to unlock the full suite of MEDICALLY features
May 6 / Roche and Genentech
Machine Learning vs Traditional Statistics: Developing a Novel Proxy for HPV-associated LA SCCHN
This analysis aimed to develop a model to predict and serve as a proxy of HPV status in LA SCCHN to improve risk stratification in RWD. The predictive performance of traditional statistical models vs. machine learning (ML) methods were also compared.
Oncology Squamous Cell Cancer ISPOR-2024
Upcoming congresses
Access to Roche and Genentech’s latest medical information
View related congresses

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.